PMGC Holdings Inc.

ELAB · Pharmaceutical Preparations

Latest available SEC filing: SCHEDULE 13D/A ·

Latest disclosures

All company filings

Institutional holders by security

Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.

  • ELAB · 73017P508 - Common Stock, $0.0001 par value per share
  • ELAB · 28622K104 - Common Stock, $0.0001 par value
  • ELAB · 73017P102 - Common Stock, $0.001 par value
  • ELAB · 73017P201 - Common Stock, par value $0.0001 per share
  • ELAB · 73017P300 - Common Stock, par value $0.0001 per share
Company details and SEC sources

CIK 0001840563 · SEC filing index. Filing dates describe disclosures, not live market data.

Ownership signals CIK-linked ownership evidence from parsed SEC filings. 1 signal
Parsed SEC ownership signals

Largest active 13D stakes

Active large-stake positions disclosed in parsed Schedule 13D filings.

NSAI NorthStrive Acquisition Corp I.
How to read these SEC ownership signals
  • Read each filing family separately: Form 13F, Schedules 13D/G, and Forms 3/4/5 answer different SEC disclosure questions and should not be blended into one ownership total.
  • Use 13F values for visible U.S.-listed equity portfolios, 13D/G rows for large beneficial-owner stakes, and Forms 3/4/5 rows for reporting-owner positions and transactions.
  • Open the linked research path when you need the filing, CIK, issuer, CUSIP, date, or source trail behind a value.
At a glance Names, identifiers, and filing context for this profile. 2 identity fields
Business address
120 Newport Center Drive, Newport Beach, CA, 92660
EDGAR profile Static EDGAR fields kept behind disclosure so the main profile stays readable. 3 profile fields available
Incorporated in
DE
Fiscal year end
31 December
Former names on EDGAR
Elevai Labs Inc. (to 27 Nov 2024), Reactive Medical Labs Inc. (to 14 Oct 2021)
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .